References
- Cuffini AM, Tullio V, Giacchino F et al. Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients. Am J Kidney Dis 2001; 37 (6): 1253–1259.
- Cuffini AM, Tullio V, Giacchino F et al. Improved phagocyte response by co-amoxiclav in renal transplant recipi-ents. Transplantation 2001; 71 (4): 575–577.
- Tullio V, Cuffini AM, De Leo C, Perrone F, Carlone NA. Interaction of Candida albicans, macrophages and flu-conazole: in-vitro and ex-vivo observations. J Chemother 1996; 8 (6): 438–444.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2“d ed. Wayne, PA: NCCLS. 2002: Test procedures.
- Tullio V, Cuffini AM, Bonino A et al. Cefonicid ‘restores’ the depressed activities of polymorphonuclear cells from chronic hemodialysis patients and renal transplant recipi-ents in vitro. Nephrol Dial Transplant 1998; 13 (8): 2017-2022.
- Iida T, Umezawa K, Tanaka K, Koga Y, Nakazawa H, Satoh T. Polymorphonuclear cells in chronic hemodialysis patients have intact phagocytotic and impaired bactericidal activities. Nephron 1997; 75 (1): 41–77.
- Pascual A, Garcia I, Conejo C, Perea EJ. Uptake and intracellular activity of fluconazole in human polymorphonu-clear leukocytes. Antimicrob Agents Chemother 1993; 37 (2): 187–190.
- Brummer E, Stevens DA. Synergy of human neutrophils with fluconazole in killing Can dida species. Mycopathologia 1996; 134 (3): 115–120.
- Wildfeuer A, Reisert I, Laufen H. Subcellular distribution and antifungal effects of fluconazole in human phagocytic cells. Demonstration of the antifungal agent in neutrophil polymorphonuclear leucocytes and monocytes by autoradiog-raphy and electron micrography. Arzneimittelforschung 1992; 42 (8): 1049–1052.